Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.570
-0.020 (-0.56%)
At close: Sep 1, 2026, 4:00 PM EDT
3.540
-0.030 (-0.84%)
After-hours: Sep 1, 2026, 7:47 PM EDT
Prime Medicine Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Maintains $7 | Buy | Maintains | $7 | +96.08% | Aug 25, 2026 |
Unknown Analyst BMO Capital No rating | BMO Capital | Buy Initiates $9 | Buy | Initiates | $9 | +152.10% | Aug 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $6 | Buy | Reiterates | $6 | +68.07% | Aug 17, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $8 | Buy | Maintains | $8 | +124.09% | Aug 10, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $5 | Buy | Maintains | $5 | +40.06% | Aug 6, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +208.12% | Jul 24, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +124.09% | Jun 23, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.